- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Aveanna Healthcare stock price target raised to $13 by Raymond James | 3 | Investing.com | ||
| 14.11. | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 10.11. | Aveanna Healthcare: RBC Kapital bestätigt "Sektor Perform"-Rating und Kursziel von 10 US-Dollar | 1 | Investing.com Deutsch | ||
| 10.11. | Aveanna Healthcare stock holds steady as RBC maintains Sector Perform rating | 2 | Investing.com | ||
| AVEANNA HEALTHCARE Aktie jetzt für 0€ handeln | |||||
| 06.11. | Aveanna outlines 2025 revenue target above $2.375B while expanding preferred payer strategy and integration of Thrive | 1 | Seeking Alpha | ||
| 06.11. | Aveanna Healthcare Holdings Non-GAAP EPS of $0.15 beats by $0.01, revenue of $621.9M beats by $30.72M | 3 | Seeking Alpha | ||
| 06.11. | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | 188 | GlobeNewswire (Europe) | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| 06.11. | Aveanna Healthcare Holdings, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 06.11. | Aveanna Healthcare Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 04.11. | Can Aveanna Drive a Strong Third Quarter on Care-Delivery Momentum? | 2 | Zacks | ||
| 24.10. | Aveanna Healthcare stock price target raised to $10 from $8 at RBC Capital | 1 | Investing.com | ||
| 24.10. | RBC Capital erhöht Kursziel für Aveanna Healthcare auf 10 US-Dollar | 1 | Investing.com Deutsch | ||
| 22.10. | Aveanna Heathcare dips 8%, prices 10M share secondary offering | 1 | Seeking Alpha | ||
| 22.10. | Aveanna Healthcare: Altaktionäre platzieren Aktienpaket zu 9 US-Dollar | 1 | Investing.com Deutsch | ||
| 22.10. | Aveanna Healthcare selling stockholders price secondary offering at $9 | 1 | Investing.com | ||
| 22.10. | Aveanna Healthcare Holdings, Inc: Aveanna Announces Pricing of Secondary Offering of Common Stock | 1 | GlobeNewswire (USA) | ||
| 21.10. | Aktienplatzierung durch Großaktionär J.H. Whitney belastet Aveanna-Aktie | 1 | Investing.com Deutsch | ||
| 21.10. | Aveanna Healthcare stock falls after J.H. Whitney announces secondary offering | 2 | Investing.com | ||
| 21.10. | Aveanna Healthcare announces preliminary third quarter financial results | 2 | Seeking Alpha | ||
| 21.10. | J.H. Whitney to sell 10 million shares of Aveanna Healthcare | 1 | Investing.com |
1 2 3 Weiter >>
56 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SENSUS HEALTHCARE | 3,360 | +0,60 % | Sensus Healthcare appoints Michael Sardano as chief commercial officer | ||
| BRIGHTSPRING HEALTH SERVICES | 35,790 | +1,79 % | IPO Stock Of The Week: Health Care Leader BrightSpring Falls Back Into Buying Range | ||
| PROCEPT BIOROBOTICS | 35,860 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,550 | +0,77 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROGYNY | 24,020 | -0,54 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| GENEDX | 158,96 | 0,00 % | Cathie Wood's ARK sells Iridium, buys GeneDx and WeRide stock | ||
| BETA BIONICS | 29,380 | 0,00 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 43,500 | +1,90 % | EQS-PVR: Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Siemens Healthineers AG
Siemens Healthineers AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
01.12.2025 /... ► Artikel lesen | |
| NUTEX HEALTH | 160,95 | 0,00 % | Nutex Health extends share repurchase plan | ||
| FRESENIUS MEDICAL CARE | 40,120 | +0,27 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| CERIBELL | 19,720 | +2,98 % | Ceribell Reports Third Quarter 2025 Financial Results | SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with... ► Artikel lesen | |
| GOODRX | 2,710 | 0,00 % | HIMS vs. GDRX: Which Consumer Health Stock Offers Greater Upside? | ||
| CLEARPOINT NEURO | 13,540 | -3,70 % | Here's What Boosted ClearPoint Neuro (CLPT) in Q3 | ||
| FRESENIUS | 48,300 | +0,60 % | DZ BANK stuft Fresenius SE auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Aktienwert für Fresenius nach den Anfang November vorgelegten Zahlen zum dritten Quartal von 56 auf 57 Euro angehoben. Die Einstufung wurde... ► Artikel lesen | |
| ADAPTHEALTH | 9,420 | 0,00 % | AdaptHealth: Strategische Expansion und Technologie-Investitionen als Wachstumstreiber |
AVEANNA HEALTHCARE HOLDINGS INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 9,310 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AVEANNA HEALTHCARE HOLDINGS INC finden Sie auf Wallstreet Online.